SGLT2 inhibitor use was associated with a significantly lower risk for androgen deprivation therapy (ADT) failure and next-generation hormonal agent failure in men with prostate cancer. SGLT2 ...

Researchers from the University of Hong Kong said on Tuesday combining imaging technology with an anti-diabetic drug ...

The Delhi High Court in January 2026 restored the Centre's ban on certain triple-drug fixed dose combinations (FDCs) used in ...

A collaborative study from the MRC Laboratory of Medical Sciences (LMS) and Imperial College London has found that the protein ACE2 may play a ...

Three newly identified compounds were found to strongly inhibit α-glucosidase, an enzyme that plays a central role in ...

With 30,000 to 40,000 yearly diabetes-induced deaths occasioned by over 300 per cent increment in medication cost ...

GLP-1 innovation & chronic care surge propel Indian pharma to a record Rs. 2.4 lakh crore valuation: Our Bureau, Chennai Thursday, January 15, 2026, 08:00 Hrs [IST] The Indian Pha ...

In accordance with the terms of the public tender, JSC Olpha will supply specific medicines to Mexican hospitals until the end of 2026. With this successful procurement result, Olpha will continue to ...

IQVIA’s India Pharmaceutical Market data for calendar year 2025, which sets the base for trends visible in early 2026, place ...

Cinnamon and nutmeg are spices that may lower blood sugar and lower the risk of diabetes. Research shows that cinnamon is more effective.

Strong domestic demand is set to lift pharma revenues by up to 11% in Q3FY26, though pressure from generic Revlimid in the US ...

Buoyant domestic sales are expected to lift revenues for pharma companies by 8-11 per cent in Q3FY26, even as declining ...